首页 | 本学科首页   官方微博 | 高级检索  
检索        

不同剂量阿托伐他汀对2型糖尿病患者血小板活性的影响
引用本文:林毅,罗助荣,盖晓波.不同剂量阿托伐他汀对2型糖尿病患者血小板活性的影响[J].中国微循环,2007,11(3):201-202,218.
作者姓名:林毅  罗助荣  盖晓波
作者单位:350025,福建福州,南京军区福州总医院心内科
摘    要:目的研究不同剂量阿托伐他汀对2型糖尿病患者血小板活性的影响。方法用酶联免疫吸附法(ELISA)测定2型糖尿病患者外周血中血栓素B2(TXB2)、血小板颗粒膜蛋白140(GMP-140)的水平,并比较不同剂量阿托伐他汀对它们的影响。结果阿托伐他汀能显著降低2型糖尿病患者外周血中TXB2、GMP-140的水平,增大剂量效果更显著,而对肝功能及血肌酸磷酸激酶(CK)影响不大。结论阿托伐他汀对2型糖尿病患者血小板活化有抑制作用,其抗血小板活性作用在一定范围内随着剂量的增加而加强,同时具有良好的安全性。

关 键 词:2型糖尿病  血小板活性  血管并发症  阿托伐他汀
文章编号:1007-8568(2007)03-0201-03
收稿时间:2006-08-07
修稿时间:2006-08-072006-10-31

Effect of Different Dosage of Atorvastatin on Platelet Activation in Patients with Type 2 Diabetes Mellitus
LIN Yi,LUO Zhu-rong,GAI Xiao-bo.Effect of Different Dosage of Atorvastatin on Platelet Activation in Patients with Type 2 Diabetes Mellitus[J].Journal of Chinese Microcirculation,2007,11(3):201-202,218.
Authors:LIN Yi  LUO Zhu-rong  GAI Xiao-bo
Institution:Fuzhou General Hospital, Fuzhou, Fujian 350025, China
Abstract:Objective To investigate the effect of different dosage of atorvastatin on platelet activation in patients with type 2 diabetes mellitus patients. Methods The levels of plasma TXB2 and GMP-140 from patients with type 2 diabetes mellitus were measured by ELISA method and were compared to observe the effect of different dosage of atorvastatin. Results Atorvastatin can significantly decrease the levels of TXB2 and GMP-140 and the effect was dose-dependant. Meanwhile, atorvastatin has no significant effects on liver function and creatine kenase (CK). Conclusion Atorvastatin has inhibitory effect on platelet activation in patients with type 2 diabetes mellitus and the effect is dose-dependent.
Keywords:Type 2 diabetes mellitus  Platelet activation  Vascular complications  Atorvastatin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号